THYMOMA - PROGNOSTIC FACTORS

被引：12

作者：

ETIENNE, T

DELEAVAL, PJ

SPILIOPOULOS, A

MEGEVAND, R

机构：

来源：

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY | 1993年 / 7卷 / 09期

关键词：

THYMOMA; THYMUS; MEDIASTINAL MASS; MEDIASTINAL NEOPLASM;

D O I：

10.1016/1010-7940(93)90272-D

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The relative importance of factors influencing prognosis and survival in the treatment of thymoma is still controversial. Fifty-three patients operated on for thymoma from 1966 to 1990 were evaluated, 14 with myasthenia gravis and 39 without. Survival was analyzed as it related to associated disease, gross invasion by the tumor and the predominant cell type. Follow-up information was obtained in all cases (mean observation time: 11.2 years). A high proportion (51%) of our patients had invasive forms (stages III and IV). The overall 5-, 10- and 20-year survival rates were 52%, 46% and 21%, respectively. Factors indicating a poor prognosis included local invasion (P < 0.0001), predominantly epithelial histologic features (P = 0.002), tumor-related symptoms and the type of surgical procedure. Myasthenia gravis was not an adverse factor for survival. The degree of tumor invasion was the main prognostic factor and treatment should be planned accordingly.

引用

页码：449 / 452

页数：4

共 16 条

[1]

Bernatz P.E., Khonsari S., Harrison E.G., Taylor W.F., Thymoma: Factors influencing prognosis, Surg Clin North Am, 53, pp. 885-892, (1973)

[2]

Etienne T., Spiliopoulos A., Megevand R., Les Thymomes. Helv Chir Acta, 51, pp. 157-162, (1984)

[3]

Goldel L., Boning L., Fredrik A., Hijlzel D., Hartenstein R., Wilmanns W., Chemotherapy of invasive thymoma. A retrospective study of 22 cases, Cancer, 63, pp. 1493-1500, (1989)

[4]

Haniuda M., Morimoto M., Nishimura H., Kobayashi O, Iida F., Adjuvant radiotherapy after complete resection of thymoma, Ann Thorac Surg, 31, (1992)

[5]

Kaplan E.L., Meier P., Nonparametric estimation from incomplete observation, J am Stat Assoc, 53, pp. 457-481, (1958)

[6]

Lewis J.E., Wick M.R., Scheithauer S.W., Bernatz P.E., Taylor W.F., Thymoma: A clinicopathologic review, Cancer, 60, pp. 2727-2743, (1987)

[7]

Loehrer P.J., Perez C.A., Roth L.M., Greco F.A., Livingston R.B., Einhorn L.H., Chemotherapy for advanced thymoma. Preliminary results of an intergroup study, Ann Intern Med, 113, pp. 520-526, (1990)

[8]

Maggi G., Casadio C., Cavallo A., Cianci R., Molinatto M., Ruffini E., Thymoma: Results of 241 operated cases, Ann Thorac Surg, 51, pp. 152-156, (1991)

[9]

Marino M., Miiller-Hermelink H.K., Thymoma and thymic carcinoma, Virchows Arch [A], 407, pp. 119-149, (1985)

[10]

Masaoka A., Monden Y., Nakahara K., Tanioka T., Follow up study of thymomas with special reference to their clinical stages, Cancer, 48, pp. 2485-2492, (1981)

← 1 2 →